Patents Assigned to Anergis, S.A.
  • Allergen peptide fragments and use thereof for treatment of birch pollen allergies
    Patent number: 9808503
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: November 7, 2017
    Assignee: ANERGIS S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof for treatment of dust mite allergies
    Patent number: 9193773
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 24, 2015
    Assignee: ANERGIS S.A..
    Inventors: Francois Spertini, Blaise Corthesy
  • Contiguous overlapping peptides for treatment of ragweed pollen allergy
    Patent number: 9005627
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of ragweed pollen Amb a 1. Such peptides while providing all potential T cell epitopes are devoid of the three-dimensional structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: April 14, 2015
    Assignee: Anergis S.A.
    Inventors: Christophe Reymond, Francois Spertini
  • ALLERGEN PEPTIDE FRAGMENTS AND USE THEREOF FOR TREATMENT OF DUST MITE ALLERGIES
    Publication number: 20140193444
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 10, 2014
    Applicant: ANERGIS S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof for treatment of dust mite allergies
    Patent number: 8703144
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: April 22, 2014
    Assignee: Anergis S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • CONTIGUOUS OVERLAPPING PEPTIDES FOR TREATMENT OF BIRCH POLLEN ALLERGY
    Publication number: 20130156799
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of birch pollen Bet v 1. Such peptides while providing all potential T cell epitopes are devoid of the 3D structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Application
    Filed: December 18, 2012
    Publication date: June 20, 2013
    Applicant: ANERGIS S.A.
    Inventor: ANERGIS S.A.
  • CONTIGUOUS OVERLAPPING PEPTIDES FOR TREATMENT OF RAGWEED POLLEN ALLERGY
    Publication number: 20130004527
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of ragweed pollen Amb a 1. Such peptides while providing all potential T cell epitopes are devoid of the three-dimensional structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Application
    Filed: June 26, 2012
    Publication date: January 3, 2013
    Applicant: ANERGIS S.A.
    Inventors: Christophe Reymond, Francois Spertini
  • Contiguous overlapping peptides for treatment of birch pollen allergy
    Patent number: 8343503
    Abstract: Contiguous overlapping peptides (COPs) for the treatment of allergic patients by Specific Immunotherapy (SIT) are provided from the sequence of the major allergen of birch pollen Bet v 1. Such peptides while providing all potential T cell epitopes are devoid of the 3D structure of the original allergen, therefore reducing their ability to bind IgE.
    Type: Grant
    Filed: February 9, 2010
    Date of Patent: January 1, 2013
    Assignee: Anergis S.A.
    Inventors: Christophe Reymond, Francois Spertini
  • ALLERGEN PEPTIDE FRAGMENTS AND USE THEREOF FOR TREATMENT OF DUST MITE ALLERGIES
    Publication number: 20120100167
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Application
    Filed: October 28, 2011
    Publication date: April 26, 2012
    Applicant: ANERGIS S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof
    Patent number: 8075897
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: December 13, 2011
    Assignee: Anergis S.A.
    Inventors: Francois Spertini, Blaise Corthesy
  • Allergen peptide fragments and use thereof
    Patent number: 7923209
    Abstract: The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 12, 2011
    Assignee: Anergis, S.A.
    Inventors: Francois Spertini, Blaise Corthesy